The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price decrease of -2.97%. However, over the past six months, we’ve seen a weaker performance of 9.50%. The price of ESPR fallen by 73.45% over the last 30 days. And in the last five days, it has surged by 2.08%.
Currently, the stock price of Esperion Therapeutics Inc (ESPR) is $1.96. In the most recent trading session, the stock underwent a significant upswing, peaking at $16.0 after opening at $1.92. The stock touched a low of $1.6 before closing at $1.79.
The stock market performance of Esperion Therapeutics Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $3.94 on 12/09/24, while the lowest price during the same time frame was $0.69, recorded on 05/15/25.
52-week price history of ESPR Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Esperion Therapeutics Inc’s current trading price is -50.25% away from its 52-week high, while its distance from the 52-week low is 183.03%. The stock’s price range for this period has been between $0.69 and $3.94. The Healthcare sector company’s shares saw a trading volume of about 3.6 million for the day, which was lower than the average daily volume of 4.66 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Esperion Therapeutics Inc (ESPR) has experienced a quarterly rise of 151.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 388.47M and boasts a workforce of 304 employees.
Expert Opinions: Analysts’ Ratings for Esperion Therapeutics Inc
As of right now, 2 analysts are rating Esperion Therapeutics Inc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.1672, with a change in price of +0.2950. Similarly, Esperion Therapeutics Inc recorded 5,038,234 in trading volume during the last 100 days, posting a change of +18.21%.
ESPR Stock Stochastic Average
As of today, the raw stochastic average of Esperion Therapeutics Inc over the past 50 days is 85.84%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 83.08%. Additionally, the Stochastic %K and %D values for the company were 76.50% and 75.73%, respectively, over the past 20 days.
